Jeffrey V. Poulton - Jun 23, 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role: Director
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Stock symbol: CRVO
Transactions as of: Jun 23, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/25/2025, 05:01 PM
Previous filing: Mar 5, 2025
Next filing: Aug 19, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Poulton Jeffrey V.	Director	20 PARK PLAZA, SUITE 424, BOSTON	/s/ William R. Elder, attorney-in-fact for the Reporting Person	2025-06-25	0001782962

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVO	Stock Option (Right to Buy)	Award	$0	+8.1K		$0.00	8.1K	Jun 23, 2025	Common Stock	8.1K	$6.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date.

Content

On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date.